Correlation Between NeuroSense Therapeutics and NLS Pharmaceutics

Can any of the company-specific risk be diversified away by investing in both NeuroSense Therapeutics and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuroSense Therapeutics and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeuroSense Therapeutics Ltd and NLS Pharmaceutics AG, you can compare the effects of market volatilities on NeuroSense Therapeutics and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuroSense Therapeutics with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuroSense Therapeutics and NLS Pharmaceutics.

Diversification Opportunities for NeuroSense Therapeutics and NLS Pharmaceutics

-0.08

Correlation Coefficient

NeuroSense Therapeutics  NLS Pharmaceutics

Good diversification

The 3 months correlation between NeuroSense and NLS is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding NeuroSense Therapeutics Ltd and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and NeuroSense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuroSense Therapeutics Ltd are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of NeuroSense Therapeutics i.e., NeuroSense Therapeutics and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between NeuroSense Therapeutics and NLS Pharmaceutics

Assuming the 90 days horizon NeuroSense Therapeutics Ltd is expected to generate 3.65 times more return on investment than NLS Pharmaceutics. However, NeuroSense Therapeutics is 3.65 times more volatile than NLS Pharmaceutics AG. It trades about 0.11 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about 0.09 per unit of risk. If you would invest  22.00  in NeuroSense Therapeutics Ltd on October 4, 2024 and sell it today you would earn a total of  22.00  from holding NeuroSense Therapeutics Ltd or generate 100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	73.74%
Values	Daily Returns

NeuroSense Therapeutics Ltd  vs.  NLS Pharmaceutics AG

NeuroSense Therapeutics

Risk-Adjusted Performance

20 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

NLS Pharmaceutics

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in NLS Pharmaceutics AG are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, NLS Pharmaceutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NeuroSense Therapeutics and NLS Pharmaceutics

The main advantage of trading using opposite NeuroSense Therapeutics and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuroSense Therapeutics position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.

The idea behind NeuroSense Therapeutics Ltd and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.